<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
0115-1721-01
</NDCCode>
<PackageDescription>
10 BLISTER PACK in 1 CARTON (0115-1721-01) / 10 TABLET, FILM COATED in 1 BLISTER PACK (0115-1721-15)
</PackageDescription>
<NDC11Code>
00115-1721-01
</NDC11Code>
<ProductNDC>
0115-1721
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Apixaban
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Apixaban
</NonProprietaryName>
<DosageFormName>
TABLET, FILM COATED
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
20180831
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
ANDA
</MarketingCategoryName>
<ApplicationNumber>
ANDA209810
</ApplicationNumber>
<LabelerName>
Amneal Pharmaceuticals of New York LLC
</LabelerName>
<SubstanceName>
APIXABAN
</SubstanceName>
<StrengthNumber>
2.5
</StrengthNumber>
<StrengthUnit>
mg/1
</StrengthUnit>
<Pharm_Classes>
Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]
</Pharm_Classes>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2025-02-25
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20180831
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>